The Osteosarcoma Tumor Microenvironment: From Cellular Interactions to Advanced Preclinical Models
Targeting TAMs, either through CSF1R inhibition or repolarization toward an M1-like phenotype using TLR agonists, represents a potential strategy to restore antitumor immunity in OS
Evidence level: Korai humán adat. Kis vagy feltáró emberi adat.
Related signals
- Potential proteins identified to target in osteosarcoma treatment
- Future Directions in the Treatment of Osteosarcoma
- Is There a Role for Mifamurtide in Nonmetastatic High‑Grade Osteosarcoma? Results From the Italian Sarcoma Group (ISG/OS‑2) and Spanish Sarcoma Group (GEIS‑33) Trials
- The clinical trial landscape of osteosarcoma: integrating trial data, immunotherapeutic trends, and biomarker insights
- Amputation and Chemotherapy for Osteosarcoma